Kazmira Therapeutics Email Format
Pharmaceutical ManufacturingColorado, United States11-50 Employees
Kazmira Therapeutics is a pharmaceutical manufacturing company based at 34501 East Quincy Avenue, Building 65, Suite C, Watkins, Colorado 80137, United States. The company develops high-purity cannabinoid ingredients free of THC and provides education to clinicians, partners, and health systems to support evidence-informed clinical practice. It operates in regulated healthcare rather than the wellness market, with rigorous quality systems, GMP-aligned manufacturing, and a clear separation between science, prescribing, and pharmacy fulfillment. Its objective is to support clinical decision-making by delivering consistent ingredients, reliable infrastructure, and disciplined standards to restore trust in cannabinoid-based medicine. The business has reported annual revenue in the range of $10 million to $25 million and announced the Chalk Cosmetics launch in August 2024.